We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
39 hedge funds and large institutions have $25.3M invested in Verrica Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
4.68% less ownership
Funds ownership: 32.5% → 27.81% (-4.7%)
22% less funds holding
Funds holding: 50 → 39 (-11)
41% less capital invested
Capital invested by funds: $43.2M → $25.3M (-$17.9M)
63% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 16
Holders
39
Holders Change
-11
Holders Change %
-22%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
7
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
+$4.39M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$456K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$354K |
| 4 |
Squarepoint
New York
|
+$269K |
| 5 |
BlackRock
New York
|
+$210K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$3.85M |
| 2 |
KCM
Kalehua Capital Management
Dallas,
Texas
|
-$1.96M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.63M |
| 4 |
Two Sigma Investments
New York
|
-$433K |
| 5 |
Jane Street
New York
|
-$336K |
